Live Breaking News & Updates on Onxeo Stock Exchange

Stay updated with breaking news from Onxeo stock exchange. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Onxeo Announces a Combined General Meeting on August 17, 2022

12.07.2022 - Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North Copenhagen: ONXEO), hereafter “Onxeo” or the “Company”, a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA . ....

France General , Nasdaq First North , Euronext Growth , General Meetings , Investor Relations , Euronext Paris ,

Onxeo S.A.: Onxeo Announces a Combined General Meeting on August 17, 2022

Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North Copenhagen: ONXEO), hereafter "Onxeo" or the "Company", a clinical-stage biotechnology company specializing in the development ....

France General , Arthur Rouill , Raymond Poincar , Onxeo Sa Euronext , Emmanuel Huynh , Renaissance Paris Nobel Tour Eiffel Hotel , Company Group , Regulatory News , Euronext Growth Paris , Nasdaq First North Copenhagen , Combined General Meeting , Mandatory Legal Notices , Nasdaq First North , Euronext Growth , General Meetingssection , Investor Relations , Euronext Paris ,

Summary of ONXEO's Liquidity Contract with Kepler Cheuvreux

Regulatory News: Under the liquidity contract entered into between ONXEO (Paris:ALONX) (NASDAQ OMX:ONXEO) and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30th ....

France General , Arthur Rouill , Kepler Cheuvreux , Emmanuel Huynh , Company Group , Regulatory News , Euronext Paris , Nasdaq First North ,

Onxeo S.A.: Onxeo: Initial IND Application for AsiDNA Granted Study May Proceed by the U.S. FDA

Onxeo to initiate its first phase 1b/2 trial in the United States in patients with solid tumors Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North Copenhagen: ONXEO) ....

United States , France General , Shefali Agarwal , Arthur Rouill , Onxeo Sa Euronext , Emmanuel Huynh , Drug Administration , Company Group , Euronext Growth Paris , Nasdaq First North Copenhagen , Euronext Paris , Nasdaq First North ,

Onxeo S.A.: Onxeo: Publication of the 2021 Annual Financial Report

Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North Copenhagen: ONXEO), hereafter "Onxeo" or the "Company", a clinical-stage biotechnology company specializing in the development ....

France General , Arthur Rouill , Onxeo Sa Euronext , Valerie Leroy , Emmanuel Huynh , Company Group , Regulatory News , Euronext Growth Paris , Nasdaq First North Copenhagen , Euronext Paris , Nasdaq First North ,